4//SEC Filing
Gemphire Therapeutics Inc. 4
Accession 0001596771-16-000140
$MTVACIK 0001638287operating
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:12 PM ET
Size
5.3 KB
Accession
0001596771-16-000140
Insider Transaction Report
Form 4
Bisgaier Charles PhD
DirectorChair & Chief Scientific Off.10% Owner
Transactions
- Award
Employee Stock Option (right to buy)
2016-08-04+150,000→ 150,000 totalExercise: $10.00Exp: 2026-08-03→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option vests in 48 equal consecutive monthly increments, so that all of the shares will be vested on the fourth anniversary of the date of grant.
Documents
Issuer
Gemphire Therapeutics Inc.
CIK 0001638287
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001638287
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 4:12 PM ET
- Size
- 5.3 KB